Neuroendocrine pathology of the stomach: The Parma contribution

Endocrine Pathology

Volumn 25, Issue 2, 2014, Pages 171-180

  Bordi, Cesare ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Anatomoclinical correlations; ECL cell; Gastrin stimulus; History; Tumor classification; Tumor genetics

Indexed keywords

FIBROBLAST GROWTH FACTOR; GASTRIN; GLYCOPROTEIN; PROTEIN BCL 2; PROTON PUMP INHIBITOR;

ARGENTAFFIN CELL; ARGENTAFFIN CELL CARCINOID TYPE 1; ARGENTAFFIN CELL CARCINOID TYPE 1 ASSOCIATED WITH CHRONIC ATROPHIC GASTRITIS TYPE A; ARGENTAFFIN CELL CARCINOID TYPE 1 ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; ARGENTAFFIN CELL CARCINOID TYPE 3; ARTICLE; ATROPHIC GASTRITIS; CARCINOGENESIS; CARCINOID; CELL PROLIFERATION; DISEASE COURSE; DUODENUM; ENDOCRINE CELL; ENDOCRINE TUMOR; ENTEROCHROMAFFIN LIKE CELL; ENTEROCHROMAFFIN LIKE CELL TUMOR TYPE 1; ENTEROCHROMAFFIN LIKE CELL TUMOR TYPE 2; ENTEROCHROMAFFIN LIKE CELL TUMOR TYPE 3; EUROENDOCRINE CARCINOMA; GASTRIC CARCINOID; GASTRIC ENTEROCHROMAFFIN LIKE CELL TUMOR; GASTRIC NEUROENDOCRINE TUMOR; GASTRIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; LUNG; MOLECULAR GENETICS; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE DISEASE; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; NONHUMAN; PANCREAS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH TUMOR; ANIMAL; CLASSIFICATION; PATHOLOGY; STOMACH NEOPLASMS;

ANIMALS; ENTEROCHROMAFFIN-LIKE CELLS; HUMANS; STOMACH NEOPLASMS;

EID: 84903627362     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-014-9315-x     Document Type: Article

References (54)

1. Bordi C, Tardini A. Electron microscopy of islet cell tumors. In: Fenoglio CM, Wolff M, (Eds). Progress in surgical pathology. New York: Masson; 1980. p.135-155.
2. Bordi C, Jemmi G, Banchini E, Costa A (1976) Problemi attuali del carcinoma midollare della tiroide. Recenti Prog Med 60:289-334.
3. Vassallo G, Capella C, Solcia E (1971) Endocrine cells of the human gastric mucosa. Z Zellforsch Mikrosk Anat 118:49-67.
4. Pearse AG, Coulling I, Weavers B, Friesen S (1970) The endocrine polypeptide cells of the human stomach, duodenum, and jejunum. Gut 11:649-658.
5. Håkanson R, Lilja B, Owman C (1969) Cellular localization of histamine and monoamines in the gastric mucosa of man. Histochemie 18:74-86.
6. Solcia E, Capella C, Vassallo G (1970) Endocrine cells of the stomach and pancreas in states of gastric hypersecretion. Rendic R Gastroenterol 2:147-158.
7. Rubin W (1969) Proliferation of endocrine-like (enterochromaffin) cells in atrophic gastric mucosa. Gastroenterology 57:641-648.
8. Pearse AG, Bussolati G (1970) Immunofluorescence studies on the distribution of gastrin cells in different clinical states. Gut 11:646-648.
9. Bordi C, Cocconi G, Togni R, Vezzadini P,Missale G (1974) Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol 98:274-278.
10. Bordi C, Costa A, Missale G (1975) ECL cell proliferation and gastrin levels. Gastroenterology 68:205-206.
11. Håkanson R, Ekelund M, Sundler F. Activation and proliferation of gastric endocrine cells. In: Falkmer S, Håkanson R, Sundler F, (Eds). Evolution and Tumour Pathology of the Neuroendocrine System. Amsterdam: Elsevier; 1984. p.371-398. (Pubitemid 15078075)
12. Håkanson R, Sundler F (1990) Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur J Clin Invest 20:S65-S71.
13. Bordi C, Ravazzola M (1979) Endocrine cells in the intestinal metaplasia of gastric mucosa. Am J Pathol 96:391-398. (Pubitemid 9235954)
14. Bordi C, Gabrielli M, Missale G (1978) Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med 102:129-135. (Pubitemid 8300704)
15. Bordi C, Ferrari C, D'Adda T, Pilato F, Carfagna G, Bertelé A,Missale G (1986) Ultrastructural characterization of fundic endocrine cell hyperplasia associated with atrophic gastritis and hypergastrinaemia. Virchows Arch A Pathol Anat Histopathol 409:335-347. (Pubitemid 16084924)
16. Bordi C, Senatore S, Missale G (1976) Gastric carcinoid following gastrojejunostomy. Am J Dig Dis 21:667-671.
17. Caruso ML, Pilato FP, D'Adda T, BaggiMT, Fucci L, Valentini AM, Lacatena M, Bordi C (1989) Composite carcinoid-adenocarcinoma of the stomach associated with multiple gastric carcinoids and nonantral gastric atrophy. Cancer 64:1534-1539. (Pubitemid 19238975)
18. D'Adda T, Pilato FP, Sivelli R, Azzoni C, Sianesi M, Bordi C (1994) Gastric carcinoid tumor and its precursor lesions. Ultrastructural study of a case before and after antrectomy. Arch Pathol Lab Med 118:658-663. (Pubitemid 24173629)
19. D'Adda T, Azzoni C, Franzé A, Bordi C (1991) Malignant enterochromaffinlike cell carcinoid of the gastric stump: an ultrastructural study. Ultrastruct Pathol 15:257-265.
20. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, Grimelius L, Havu N (1988) Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41:185-200. (Pubitemid 19070318)
21. D'Adda T, Bertelé A, Pilato FP, Bordi C (1989) Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res 255:41-48. (Pubitemid 19017912)
22. D'Adda T, Corleto V, Pilato FP, Baggi MT, Robutti F, Delle Fave G, Bordi C (1990) Quantitative ultrastructure of endocrine cells of oxynticmucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology 99:17-26. (Pubitemid 20202485)
23. D'Adda T, Pilato FP, LazzaroniM, Robutti F, Bianchi-Porro G, Bordi C (1991) Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients. Gastroenterology 100:1563-1570.
24. Havu N (1986) Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35:42-55.
25. Bordi C, Annibale B, Azzoni C, Marignani M, Ferraro G, Antonelli G, D'Adda T, D'Ambra G, Delle Fave G (1997) Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. J Pathol 182:339-346. (Pubitemid 27285788)
26. Heitz PU, Kasper M, Klöppel G, Polak JM, Vaitukaitis JL (1983) Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Cancer 51:277-282.
27. Bordi C, Pilato FP, Bertelé A, D'Adda T, Missale G (1988) Expression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia. Hum Pathol 19:580-585.
28. Bordi C, Falchetti A, Buffa R, Azzoni C, D'Adda T, Caruana P, Rindi G, BrandiML (1994) Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin. HumPathol 25:175-180. (Pubitemid 24079639)
29. Bordi C, D'Adda T, Azzoni C, Ferraro G (1998) Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 71:273-284.
30. Bordi C, Azzoni C, Ferraro G, Corleto VD, Gibril F, Delle Fave G, Lubensky IA, Venzon DJ, Jensen RT. (2000) Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome. Am J Clin Pathol 114:419-425. (Pubitemid 33049678)
31. Peghini PL, Annibale B, Azzoni C, Milione M, Corleto VD, Gibril F, Venzon DJ, Delle Fave G, Bordi C, Jensen RT (2002) Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology 123:68-85. (Pubitemid 34747527)
32. Berna MJ, Annibale B, Marignani M, Luong TV, Corleto V, Pace A, Ito T, Liewehr D, Venzon DJ, Delle Fave G, Bordi C, Jensen RT (2008) A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 93:1582-1591. (Pubitemid 351656492)
33. Ojeaburu JV, Ito T, Crafa P, Bordi C, Jensen RT (2011)Mechanism of acid hypersecretion post curative gastrinoma resection. Dig Dis Sci 56:139-154.
34. Bordi C, Yu JY, Baggi MT, Davoli C, Pilato FP, Baruzzi G, Gardini G, Zamboni G, Franzin G, Papotti M, Bussolati G (1991) Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 67:663-672.
35. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E (1993) Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104:994-1006. (Pubitemid 23090750)
36. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J (1990) Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 14:503-513. (Pubitemid 20172521)
37. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, Santini D, Tomassetti P, Brandi ML (1997) Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21:1075-1082. (Pubitemid 27407292)
38. Norton JA, Melcher ML, Gibril F, Jensen RT (2004) Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136:1267-1274. (Pubitemid 39647544)
39. Bordi C, Azzoni C, D'Adda T, Caruana P, Carlinfante G (1997) Neuroendokrine Tumoren Des Magens: Pathogenese, Klassifikation Und Klinik. Der Pathologe 18:313-321. (Pubitemid 27403843)
40. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, Stolte M, Capella C, Bordi C, Solcia E (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116:532-542. (Pubitemid 29106760)
41. Solcia E, Kloppel G, Sobin LH. Histological Typing of Endocrine Tumours. WHO International Histological Classification of Tumours. Springer: Heidelberg, 2000.
42. Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256-265.
43. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, KörnerM, Lopes JM,McNicolAM, NilssonO, Perren A, ScarpaA, Scoazec JY, Wiedenmann B. (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395-401. (Pubitemid 44451313)
44. La Rosa S, Inzani F, Vanoli A, Klersy C, Dainese L, Rindi G, Capella C, Bordi C, Solcia E (2011) Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol 42:1373-1384.
45. Solcia E, Arnold R, Capella C, Klimstra DS,Klöppel G,Komminoth P, Rindi G. Neuroendocrine Neoplasms Of The Stomach. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, (Eds). WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010. p.64-68.
46. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87. (Pubitemid 18083554)
47. Debelenko LV, Emmert-BuckMR, Zhuang Z, Epshteyn E,Moskaluk CA, Jensen RT, Liotta LA, Lubensky IA (1997) The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 113:773-781. (Pubitemid 27381136)
48. D'Adda T, Keller G, Bordi C, Höfler H (1999) Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest 79:671-677. (Pubitemid 29283420)
49. D'Adda T, Candidus S, Denk H, Bordi C, Höfler H (1999) Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. J Pathol 189:394-401. (Pubitemid 29489225)
50. Pizzi S, D'Adda T, Azzoni C, Rindi G, Grigolato P, Pasquali C, Corleto VD, Delle Fave G, Bordi C (2002) Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours. J Pathol 196:401-407. (Pubitemid 34262851)
51. D'Adda T, Bottarelli L, Azzoni C, Pizzi S, Bongiovanni M, Papotti M, Pelosi G, Maisonneuve P, Antonetti T, Rindi G, Bordi C (2005) Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors. Mod Pathol 18: 795-805. (Pubitemid 40780513)
52. Pizzi S, Azzoni C, Bottarelli L, Campanini N, D'Adda T, Pasquali C, Rossi G, Rindi G, Bordi C (2005) RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J Pathol 206:409-416. (Pubitemid 41025343)
53. ToliatMR, BergerW, Ropers HH, Neuhaus P,Wiedenmann B (1997) Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system. Lancet 350:1223. (Pubitemid 127445099)
54. D'Adda T, Pizzi S, Azzoni C, Bottarelli L, Crafa P, Pasquali C,Davoli C, Corleto VD, Delle Fave G, Bordi C (2002) Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol 33:322-329. (Pubitemid 34461466)